Preventives or remedies for diseases affecting excessive proliferation of retinal pigment epithelial cells
US6303655A · kind A · utility
13Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 1999 |
| Grant date | Oct 16, 2001 |
| Priority date | — |
| Expiry date | Oct 18, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an agent for the prevention or treatment of diseases associated with excessive proliferation of retinal pigment epithelial cells such as proliferative vitreoretinopathy comprising as the active ingredient N-(3,4-dimethoxycinnamoyl)anthranilic acid represented by the formula: ##STR1## or a pharmaceutically acceptable salt thereof, which has an inhibitory activity on proliferation of retinal pigment epithelial cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.